Challenge
A life sciences company specializing in the development and manufacturing of acellular tissues for the treatment of diseases, injuries, and chronic conditions faced significant hurdles in managing clinical trial data. Their reliance on costly IT systems for data submission, coupled with the potential for audit and inspection risks, threatened the security and integrity of their regulated clinical trial and biostatistics data.
Compounding the problem, the company struggled to share data efficiently between Contract Research Organizations (CROs), creating silos that slowed down operations and collaboration. Without a centralized, validated platform, maintaining data integrity and proving 21 CFR Part 11 compliance across regulated datasets was both expensive and error-prone.
Approach
USDM delivered a comprehensive solution leveraging its expertise in data management and cloud technologies. The team architected and implemented a robust AWS-based scalable and secure Clinical Data Lake. This platform streamlined the storage and analysis of diverse datasets, including research and biostatistics data. USDM then validated the centralized data platform, reducing the complexity and cost associated with maintenance, security, and compliance.
Validation followed a risk-based Computer Software Assurance (CSA) approach, focusing testing effort where it most protects patient safety and data integrity rather than on exhaustive paperwork.
Key elements of the solution included:
- Centralized Data Management: A unified repository for storing and accessing clinical and biostatistics data.
- Regulatory Compliance: Ensured full adherence to regulatory requirements while maintaining data security and integrity.
- Advanced Analytics Enablement: Enabled clinical users to perform advanced analytics and reporting through SAS, R, and machine learning tools.
- AWS Data Lake Integration: Optimized costs through tiered storage while ensuring high-performance analytics capabilities.
- Enterprise-Grade Security: Delivered encryption and granular access controls to protect sensitive data from unauthorized access.
Because the platform handled regulated data flowing between multiple external CROs, USDM also addressed third-party risk and cybersecurity controls as part of the design — keeping the environment secure and audit-ready as collaboration scaled.
Results
The implementation of USDM's solution delivered measurable results:
Compliance and Risk Management
- Achieved 100% GxP compliance across AWS environments.
- Reduced audit preparation time by 60%, enhancing regulatory readiness.
Operational Efficiency
- Accelerated deployment of new cloud services by 50%, driving faster project execution.
Cost Savings
- Saved an estimated $500,000 annually by optimizing cloud storage and operations.
Innovation Enablement
- Enabled real-time data sharing and analysis, fostering a culture of transparency and collaboration.
- Provided a scalable foundation for Gen AI enablement, paving the way for future digital transformation — supported by emerging AI governance and compliance practices.
USDM's solution gave the client a future-ready platform — enabling seamless collaboration with CROs, ensuring regulatory compliance, and setting the foundation for continued innovation in clinical trial management. By pairing a validated cloud architecture with a continuous compliance posture, USDM demonstrated its ability to deliver secure, compliant, and scalable data management solutions tailored to the life sciences sector.